FSB Premier Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $358K | Sell |
1,928
-243
| -11% | -$45.1K | 0.13% | 157 |
|
|
2025
Q1 | $455K | Buy |
2,171
+285
| +15% | +$59.7K | 0.18% | 129 |
|
|
2024
Q4 | $335K | Hold |
1,886
| – | – | 0.13% | 155 |
|
|
2024
Q3 | $372K | Buy |
1,886
+116
| +7% | +$22.9K | 0.15% | 145 |
|
|
2024
Q2 | $304K | Buy |
1,770
+5
| +0.3% | +$857 | 0.14% | 144 |
|
|
2024
Q1 | $321K | Buy |
1,765
+5
| +0.3% | +$910 | 0.15% | 133 |
|
|
2023
Q4 | $273K | Buy |
1,760
+4
| +0.2% | +$620 | 0.14% | 137 |
|
|
2023
Q3 | $262K | Buy |
1,756
+5
| +0.3% | +$745 | 0.15% | 126 |
|
|
2023
Q2 | $236K | Buy |
1,751
+8
| +0.5% | +$1.08K | 0.13% | 135 |
|
|
2023
Q1 | $278K | Buy |
1,743
+62
| +4% | +$9.88K | 0.15% | 116 |
|
|
2022
Q4 | $272K | Buy |
1,681
+4
| +0.2% | +$647 | 0.15% | 120 |
|
|
2022
Q3 | $225K | Buy |
1,677
+3
| +0.2% | +$403 | 0.13% | 124 |
|
|
2022
Q2 | $256K | Sell |
1,674
-136
| -8% | -$20.8K | 0.14% | 121 |
|
|
2022
Q1 | $283K | Buy |
1,810
+35
| +2% | +$5.47K | 0.14% | 114 |
|
|
2021
Q4 | $240K | Buy |
+1,775
| New | +$240K | 0.1% | 118 |
|
|
2021
Q3 | – | Sell |
-1,997
| Closed | -$225K | – | 105 |
|
|
2021
Q2 | $225K | Buy |
1,997
+4
| +0.2% | +$451 | 0.12% | 95 |
|
|
2021
Q1 | $215K | Sell |
1,993
-614
| -24% | -$66.2K | 0.12% | 93 |
|
|
2020
Q4 | $279K | Buy |
+2,607
| New | +$279K | 0.15% | 86 |
|